Validation of osteoporosis risk assessment tools: ORAI (osteoporosis risk assessment instrument), OSIRIS (osteoporosis index of risk) and SCORE (simple calculated osteoporosis risk estimation), and their comparative evaluation using dual energy x-ray absorptiometry (DXA): a cross-sectional study
Publication Date
2000
Document Type
Research
Abstract
Osteoporosis is the most common metabolic bone disease, affecting up to 40% of postmenopausal women. This study was conducted to validate different osteoporosis risk assessment tools that can be used to screen local patients who may be at increased risk for osteoporosis and may warrant further evaluation using DXA and eventual treatment. Patients referred for DXA scans at the Nuclear Medicine Laboratory of the Department of Radiology at De La Salle University Medical Center from January 2016 to December 2017 were included in the study. The results showed that, among the three tools evaluated, OSIRIS is the best tool for screening patients who are least likely to be osteoporotic and who do not require immediate referral for DXA. Therefore, among patients being screened for osteoporosis—especially those who are economically challenged—OSIRIS is recommended to help determine whether undergoing a DXA scan is necessary. This may potentially eliminate unnecessary expenses for patients in the future.
APA Citation
Almaden, Vanessa A. and Pauco, Arnel E., "Validation of osteoporosis risk assessment tools: ORAI (osteoporosis risk assessment instrument), OSIRIS (osteoporosis index of risk) and SCORE (simple calculated osteoporosis risk estimation), and their comparative evaluation using dual energy x-ray absorptiometry (DXA): a cross-sectional study" (2000). Resident Research. 111.
https://greenprints.dlshsi.edu.ph/resident-research/111